Total Synthesis of 7-Ethyl-10-hydroxycamptothecin (SN38) and its Application to the Development of C18-Functionalized Camptothecin Derivatives

被引:15
|
作者
Yao, Yuan-Shan [2 ,3 ]
Liu, Jia-Li [1 ]
Xi, Jie [2 ]
Miu, Bukeyan [2 ]
Liu, Guai-Sai [2 ]
Wang, Shaozhong [2 ]
Meng, Linghua [1 ]
Yao, Zhu-Jun [2 ]
机构
[1] Chinese Acad Sci, Div Antitumor Pharmacol, State Key Lab Drug Res, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China
[2] Nanjing Univ, State Key Lab Coordinat Chem, Nanjing Natl Lab Microstruct, Inst Chem Biol & Drug Innovat,Sch Chem & Chem Eng, Nanjing 210093, Jiangsu, Peoples R China
[3] Univ Sci & Technol China, Joint Lab Green Chem, Dept Chem, Hefei 230026, Anhui, Peoples R China
关键词
antitumor agents; camptothecin derivatives; Diels-Alder reaction; structure-activity relationships; total synthesis; PLANT ANTITUMOR AGENTS; IN-VITRO CYTOTOXICITY; ASYMMETRIC-SYNTHESIS; EFFICIENT; RING; (+)-CAMPTOTHECIN; CYCLIZATION; IRINOTECAN; INHIBITOR; CANCER;
D O I
10.1002/chem.201101389
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A new chemical synthesis of SN38, the active metabolite of the camptothecin prodrug irinotecan, has been achieved in 12 steps from simple, commercially available starting materials. A mild and efficient FeCl3-catalyzed Friedlander condensation was successfully applied to construct the AB ring system. Functionalization of the C ring was accomplished by a vinylogous Mukaiyama reaction of an in situ generated N-acyliminium intermediate with a silyl enol ether. An intramolecular oxa Diels-Alder reaction efficiently constructed the D and E rings in one step. Successive asymmetric dihydroxylation and I-2-based hemiacetal oxidation furnished the stereo-chemistry of SN38 with high enantiopurity. Utilizing the ABC-ring intermediate and a functionalized silyl enol ether permitted the synthesis of a number of new C18-functionalized SN38 derivatives. Several of the novel SN38 derivatives that bore a C10 methoxy group were found to exhibit comparable or more potent inhibitory activity against the proliferation of cancer cells relative to SN38.
引用
收藏
页码:10462 / 10469
页数:8
相关论文
共 46 条
  • [1] Redox responsive 7-ethyl-10-hydroxycamptothecin (SN38) lysophospholipid conjugate: synthesis, assembly and anticancer evaluation
    He, Wei
    Du, Yawei
    Wang, Tao
    Wang, Ji
    Cheng, Lei
    Li, Xinsong
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2021, 606
  • [2] Human Serum Albumin Conjugates of 7-Ethyl-10-hydroxycamptothecin (SN38) for Cancer Treatment
    Sepehri, Nima
    Rouhani, Hasti
    Ghanbarpour, Ahmad Reza
    Gharghabi, Mehdi
    Tavassolian, Faranak
    Amini, Mohsen
    Ostad, Seyed Nasser
    Ghahremani, Mohammad Hossein
    Dinarvand, Rassoul
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [3] Solid lipid nanoparticles containing 7-ethyl-10-hydroxycamptothecin (SN38): Preparation, characterization, in vitro, and in vivo evaluations
    Mosallaei, Navid
    Mahmoudi, Asma
    Ghandehari, Hamidreza
    Yellepeddi, Venkata Kashyap
    Jaafari, Mahmoud Reza
    Malaekeh-Nikouei, Bizhan
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2016, 104 : 42 - 50
  • [4] Antibody Conjugates of 7-Ethyl-10-hydroxycamptothecin (SN-38) for Targeted Cancer Chemotherapy
    Moon, Sung-Ju
    Govindan, Serengulam V.
    Cardillo, Thomas M.
    D'Souza, Christopher A.
    Hansen, Hans J.
    Goldenberg, David M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (21) : 6916 - 6926
  • [5] ABCG2 mediates differential resistance to SN-38 (7-ethyl-10-hydroxycamptothecin) and homocamptothecins
    Bates, SE
    Medina-Pérez, WY
    Kohlhagen, G
    Antony, S
    Nadjem, T
    Robey, RW
    Pommier, Y
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 310 (02): : 836 - 842
  • [6] SYNTHESIS AND ANTITUMOR-ACTIVITY OF 20(S)-CAMPTOTHECIN DERIVATIVES - CARBAMATE-LINKED, WATER-SOLUBLE DERIVATIVES OF 7-ETHYL-10-HYDROXYCAMPTOTHECIN
    SAWADA, S
    OKAJIMA, S
    AIYAMA, R
    NOKATA, K
    FURUTA, T
    YOKOKURA, T
    SUGINO, E
    YAMAGUCHI, K
    MIYASAKA, T
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1991, 39 (06) : 1446 - 1454
  • [7] Conversion of irinotecan (CPT-11) to its active metabolite, 7-ethyl-10-hydroxycamptothecin (SN-38), by human liver carboxylesterase
    Rivory, LP
    Bowles, MR
    Robert, J
    Pond, SM
    BIOCHEMICAL PHARMACOLOGY, 1996, 52 (07) : 1103 - 1111
  • [8] Polymeric micelles loaded with 7-ethyl-10-hydroxy camptothecin (SN38) as effective antitumor nanoformulation
    Hu, Shiqi
    Shen, Youqing
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2016, 12 (02) : 462 - 463
  • [9] A convergent fabrication of 7-ethyl-10-hydroxycamptothecin (SN-38)-loaded cobalt ferrite nanocarrier delivery for lung treatment
    Yang, Yu
    Alahmadi, Tahani Awad
    Alharbi, Sulaiman Ali
    Wainwright, Milton
    MATERIALS EXPRESS, 2023, 13 (05) : 829 - 838
  • [10] Cancer chemotherapy: A SN-38 (7-ethyl-10-hydroxycamptothecin) glucuronide prodrug for treatment by a PMT (Prodrug MonoTherapy) strategy
    Angenault, S
    Thirot, S
    Schmidt, F
    Monneret, C
    Pfeiffer, B
    Renard, P
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (05) : 947 - 950